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Engineering brain organoids from human induced pluripotent stem cells (hiPSCs) is a
powerful tool for modeling brain development and neurological disorders. Rett syndrome
(RTT), a rare neurodevelopmental disorder, can greatly benefit from this technology,
since it affects multiple neuronal subtypes in forebrain sub-regions. We have established
dorsal and ventral forebrain organoids from control and RTT patient-specific hiPSCs
recapitulating 3D organization and functional network complexity. Our data revealed
a premature development of the deep-cortical layer, associated to the formation of
TBR1 and CTIP2 neurons, and a lower expression of neural progenitor/proliferative
cells in female RTT dorsal organoids. Moreover, calcium imaging and electrophysiology
analysis demonstrated functional defects of RTT neurons. Additionally, assembly of
RTT dorsal and ventral organoids revealed impairments of interneuron’s migration.
Overall, our models provide a better understanding of RTT during early stages of
neural development, demonstrating a great potential for personalized diagnosis and
drug screening.
Keywords: human induced pluripotent stem cells, organoids, forebrain, Rett syndrome, disease modeling,
neurodevelopmental disorders
INTRODUCTION
Rett syndrome (RTT) is a severe neurological disorder that affects brain development and function
in approximately 1 in 10.000 live births, and it is caused by mutations in the gene encoding for
methyl-CpG-binding protein 2 (MeCP2). MeCP2 mutations in females lead to developmental
regression after 6–18 months after birth, with a range of neurodevelopmental defects, including loss
of speech, acquired movement skills and severe cognitive impairment after an apparently normal
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development. Less frequent, MeCP2 mutations in males usually
lead to wide spectrum of symptoms, from mild mental
retardations to severe congenital encephalopathies and death
within the first 2 years of age (Chahrour and Zoghbi, 2007). The
range of RTT phenotypes is large and varies according to the
mutations, with missense and nonsense mutations accounting
for the majority, while small C-terminal deletions and complex
rearrangements are less frequent (Chahrour and Zoghbi, 2007).
TheMeCP2 gene is localized on the X-chromosome, which causes
the disease to be presented in females in a mosaic pattern, with
some cells expressing the wild-type MeCP2 allele and others the
mutant (Ananiev et al., 2011).
Rett syndrome has been studied using post-mortem samples
of human brain (Colantuoni et al., 2001), as well as transgenic
mouse models (Chen et al., 2001). However, the onset of
neurological symptoms in mice can be less severe (Veeraragavan
et al., 2016) and does not fully recapitulate the phenotypic aspects
of human RTT. Recently, RTT was modeled using neural cells
differentiated from patient-specific hiPSCs with MeCP2-mutant
neurons exhibiting impaired maturation, including the presence
of fewer synapses, smaller soma size, altered calcium signaling,
functional defects in firing activity and excitatory/inhibitory
(E/I) imbalance (Marchetto et al., 2010; Ananiev et al., 2011;
Fernandes et al., 2015; Tang et al., 2016). However, in the majority
of these studies, neural differentiation was performed in 2D
adherent monolayer, which provides a simplistic recapitulation
of the human cortex development. As a recent innovation in the
stem cell field, organoid techniques provide unique platforms to
model brain development and neurological disorders (Lancaster
et al., 2013). 3D cerebral organoids derived from hiPSCs were
recently used for RTT modeling, reveling a decrease in neurite
growth, neurite coalescence, and soma size of interneurons
(Xiang et al., 2020), in addition to impaired neurogenesis and
neural progenitor’s migration deficits (Mellios et al., 2017).
However, in cerebral organoids all the regions of the brain
are co-generated together, which causes the differentiation
process to be poorly controlled and non-region specific (Qian
et al., 2016). To overcome these limitations, it is possible to
generate independently distinct organoids recapitulating the
dorsal and ventral regions of the forebrain (Bagley et al., 2017).
In vivo, the dorsal forebrain contains the majority of excitatory
glutamatergic pyramidal neurons, whereas some evidences in
the literature claim that inhibitory g-aminobutyric acid (GABA)-
producing interneurons are originated in the ventral region,
integrating the dorsal cortical circuit upon migration. Ultimately,
forebrain multilineage assembloids can be patterned to contain
a dorsal–ventral axis and then used to recapitulate human
interneuron migration (Bagley et al., 2017; Xiang et al., 2017;
Sloan et al., 2018).
In this study, we generated dorsal, ventral and assembled
3D forebrain organoids from RTT patient-derived hiPSCs and
their isogenic pair (IC), as well as from several healthy control
hiPSCs. These in vitro humanized models were used for studying
RTT-derived molecular, structural and functional alterations.
Intriguingly, our findings suggest that neural progenitors in
dorsal organoids derived from RTT female hiPSCs undergo a
premature transition into early born neurons, yielding neurons
with functional deficits. Our results also propose impairments in
the formation of medial ganglionic eminence (MGE) progenitors
in ventral organoids, which seems to impact negatively on
interneuron’s migration process. Overall, these human in vitro 3D
models of RTT recapitulate previously reported hallmarks of the
disease while providing new clues for the molecular mechanisms
involved in this syndrome.
MATERIALS AND METHODS
hiPSC Lines and Maintenance
We used four healthy-control hiPSCs lines and two hiPSCs
lines derived from patients with RTT-associated mutations. The
healthy-control hiPSC lines were F002.1A.13 [46, XX cell line
derived from a health donor by TCLab (Tecnologias Celulares
para Aplicação Médica, Unipessoal, Lda.)], reprogrammed using
a standard protocol by Takahashi et al. (2007); Gibco R© iPSC6.2
(46, XY human Episomal cell line, from a healthy donor) and
iPS-DF6-9-9T.B (46, XY cell line, reprogrammed from foreskin
fibroblasts, collected from healthy donors, using defined factors,
in the Laboratory of Dr. James Thomson, at University of
Wisconsin, and provided by WiCell Bank). All the previous
healthy hiPSCs-controls were purchased under MTAs. The
RTT cell lines were EMC25i/WT-R/F7 (46, XX cell line,
derived from a healthy donor); EMC24i/R2 (C6) [46, XX cell
line of a RTT patient with mutation at MECP2 (R255X), a
nonsense mutation on C to T transitions at hypermutable CpG
sites within the gene] and EMC24i/R2 (C5) (the respective
isogenic cell line). The last three cell lines were derived by
reprogramming skin fibroblasts ensuring data protection issues.
Human skin punch biopsy samples (3 mm) were collected
using a standard technique. The protocol was established with
the Paediatric Surgery Department at Centro Hospitalar de
Lisboa Norte (CHLN) to collect skin samples during minor
surgeries. Biopsy tissue was expanded at Instituto de Medicina
Molecular, Lisboa. Hospital Sant Joan de Déu (HSJD) and CHLN
Ethic Committees approved the study and written informed
consent was obtained from patient’s legal guardians. Then, the
reprogramming of fibroblasts was performed at the iPSC Facility,
Erasmus Medical Center, Rotterdam, using engineered color-
coded lentiviral vectors (Varga et al., 2016). Moreover, a RTT
male cell line was also used, Rett Male: Q83X (46, XY cell
line, derived from fibroblasts of a RTT male patient with a
mutation at the amino acid residue 83 from glutamine to a
premature stop codon, resulting in truncation and degradation
of the MeCP2 protein). This cell line was donated by Alysson
Muotri Lab at UCSD, United States, under an MTA. These
cells were reprogrammed with retroviral reprogramming vectors
(Sox2, Oct4, c-Myc, and Klf4) (Takahashi and Yamanaka, 2006),
and provided by University of California, San Diego Campus and
approved by the institutional review boards at Salk Institute for
Biological Studies and University of California, San Diego, as well
as Pennsylvania State University (Marchetto et al., 2010).
All the hiPSCs lines were cultured on MatrigelTM (Corning)-
coated plates with either Essential 8TM Medium (Thermofisher
Scientific) or mTeSRTM1 Plus Medium (StemCell Technologies).
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Medium was changed according to the respective procedures.
Cells were passaged every 3–4 days (at approximately 85%
of cell confluence) using 0.5 mM EDTA dissociation buffer
(Thermofisher Scientific). Before starting the differentiation
process, two to three passages were performed.
3D Induction of Dorsal and Ventral
Forebrain Organoids
Before starting the ventral and dorsal neural induction
protocols, the hiPSC were incubated with ROCK inhibitor
(ROCKi, Y-27632, 10 µM, StemCell Technologies) for
30 min at 37◦C and then treated with accutase (Sigma)
for 5 min at 37◦C. After dissociation, cells were seeded on
microwell plates (AggreWellTM800, StemCell Technologies)
according to the manufacturer’s instructions. The cell density
used was 1.5 × 106 cells/well in 1.5 mL/well of E8TM or
mTeSRTM1 Plus supplemented with 10 µM ROCKi. The entire
expansion medium was changed after 24 h, without ROCKi
supplementation. Usually after 2–3 days, when the aggregates
attained a diameter of 250–300 µm, the medium was half-
changed to induction medium, and this day was defined as day
0. The neural induction medium used was N2B27, composed by
50% of DMEM/F12/N2 (DMEM-F12, (Thermofisher Scientific)
supplemented with 1% (v/v) N2 (Thermofisher Scientific),
1.6 g/L Glucose (Sigma), 1% (v/v) PenStrep, and 20 µg/mL
Insulin (Sigma) and 50% of Neurobasal/B27 [Neurobasal
medium (Thermofisher Scientific) supplemented with 2% (v/v)
B27(-Vitamin A)-supplement (Thermofisher Scientific), 2 mM
L-glutamine (Thermofisher Scientific) and 1% (v/v) PenStrep].
For the dorsal forebrain patterning, the previously described
medium was supplemented with 2 µM Dorsomorphine (Sigma)
and 2 µM A83-01 (Tocris) until day 5, with half-medium
changed at days 0, 3 and 5. For the ventral patterned aggregates,
the medium was supplemented with 10 µM SB-431542 (SB)
(Sigma) and 100 nM LDN-193189 (LDN) (Stemgent). At day
5, cell aggregates (around 300 aggregates per each well of the
microwell plate used) were collected from the microwell plates
and seeded in an Ultra-Low attachment 6-well plate (Corning).
At day 7, half of the medium was changed for both dorsal and
ventral patterning. In dorsal patterning cultures, the medium
was supplemented with 1 µM CHIR99021 (Stemgent), 10 µM
SB-431542 (Sigma) and 10 µg/ml Heparin (Sigma) and ventral
patterning culture medium was supplemented with 2.5 µM
IWP2 (Stemgent), 100 nM SAG (Millipore) and 10 µg/ml
Heparin (Sigma). When required, on day 13, the assembly of one
dorsal with one ventral organoid was performed inside a 96-TC
Plate, Suspension, C (Sarstedt) and after 24 h the fused organoid
was transferred into an Ultra-Low attachment 24-well plate.
Maintenance and Maturation of Dorsal,
Ventral and Fused Organoids
On day 13, the medium was half-changed to N2B27 (+Vitamin
A) without any small molecule supplementation and was
maintained in the presence of this medium until day 41. This
medium was replaced every 2/3 days. On day 41 of differentiation,
the organoids were cultured in BrainPhysTM Neuronal Medium
(StemCell Technologies), supplemented with NeuroCultTM SM1
Neuronal Supplement (StemCell Technologies), N2 Supplement-
A (StemCell Technologies), Recombinant Human Brain
Derived Neurotrophic Factor (BDNF, PeproTech, 20 ng/mL),
Recombinant Human Glial-Derived Neurotrophic Factor
(GDNF, PeproTech, 20 ng/mL), dibutyryl cAMP (1 mM, Sigma),
and ascorbic acid (200 nM, Sigma). One third of the total volume
was replaced every 2–3 days.
Tissue Preparation and Immunostaining
Organoids replated in coverslips were fixed in 4% (w/v) PFA
(Sigma) for 20 min at 4◦C, followed by washing in phosphate
buffered saline (PBS, 0.1M). Whole 3D organoids were fixed
in 4% PFA for 30 min at 4◦C, with agitation, followed by
washing in PBS 0.1M and overnight incubation in 15% (w/v)
sucrose at 4◦C. Then, they were embedded in 7.5% gelatin/15%
sucrose and isopenthane (Sigma) was subsequently used for
freezing at−80◦C. A cryostat-microtome (Leica CM3050S, Leica
Microsystems) was used to prepare organoid sections with
approximately 12 µm thickness and collected on SuperfrostTM
Microscope Slides (Thermo Scientific) (stored at −20◦C).
Organoid sections were de-gelatinized in PBS at 37◦C for 45 min
and then analyzed by immunohistochemistry. Organoid sections
and cells plated on coverslips were then incubated in 0.1 M
Glycine (Millipore) for 10 min at room temperature (RT),
permeabilized with 0.1% Triton X-100 (Sigma) for 10 min at RT,
and blocked with 10% fetal bovine serum (FBS, Thermofisher
Scientific) in TBST [20 mM Tris-HCl pH 8.0, 150 mM NaCl,
0.05% (v/v) Tween-20, Sigma] for 1 h at RT. Then, primary
antibodies were diluted in blocking solution and incubated
overnight at 4◦C. After three washing steps with TBST, secondary
antibodies were incubated for 45 min at RT. For phalloidin
staining, cells were incubated with Alexa Fluor R© 488 Phalloidin
during 30 min (1:50 in PBS, Thermofisher Scientific). For GFP
staining, cryosections were incubated with anti-GFP polyclonal
IgG, Alexa Fluor R©–488. Nuclear counterstaining was performed
using 4′,6-diamidino-2-phenylindole (DAPI, 1.5 µg/mL; Sigma).
After drying, sections and coverslips were mounted in Mowiol
(Sigma). Fluorescence images were acquired using Zeiss LSM 710
Confocal Laser Point-Scanning Microscopes and images were
processed in ZEN 2.3 blue edition software (Zeiss).
Flow Cytometry
Samples were collected with accutase (Sigma) for 5 min at
37◦C and then stored in 2% w/v PFA (Sigma). Samples were
centrifuged at 1000 rpm for 5 min and washed twice with PBS.
Samples for KI67 analyzes were also collected with accutase, and
then fixed drop by drop with 70% (v/v) ethanol (−20◦C) with
vortex. Samples were stored at −20◦C, being then centrifuged
at 1000 rpm for 10 min and washed twice with PBS. The
Eppendorf tubes were coated with 1% v/v bovine serum albumin
(BSA; Thermofisher Scientific) solution in PBS for 15 min. For
intracellular staining, cell were resuspended in 3% (v/v) normal
goat serum (NGS, Sigma), at approximately 1 × 106 cells per
condition. The cell suspension was centrifuged again at 1000 rpm
for 3 min. The cell membrane was then permeabilized using a
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solution 1:1 of 3% (v/v) NGS and 1% (v/v) saponin (Sigma) for
15 min, at RT. After washing three times with 1% (v/v) NGS, cells
were resuspended in primary antibody solution (in 3% NGS) and
incubated for 1 h at room temperature. Cells were then washed
three times with 1% NGS, and incubated for 30 min in the dark
with the secondary antibody (in 3% NGS) and 300 µL were
transferred to a FACS (flow cytometry) tube. For surface staining,
cells were resuspended in primary antibody diluted in 10% (v/v)
FBS in PBS, at approximately 0.5 × 106 cells per condition, and
incubated for 30 min at RT. Finally, cells were washed with PBS
and resuspended in 10% (v/v) FBS in PBS and incubated with
secondary antibodies for 15 min, at room temperature. After
another washing step, cells were resuspended in PBS and 300 µL
were transferred to a flow cytometry tube. Flow cytometry was
performed using a FACSCaliburTM flow cytometer (by Becton
Dickinson) and the data acquisition was performed with the Cell
Quest software (Becton Dickinson). A minimum of 10,000 events
were analyzed for each sample. The data analysis was performed
using Flowing Software 2.0. As negative controls, unstained
samples and samples stained with only the secondary antibody
were used, without showing relevant differences between them.
The gate was selected to contain less than 1% of false positives
(i.e., 1% of the negative control samples). Primary antibodies used
for flow cytometry were SSEA-4-PE (Miltenyi Biotec, 1:10) for
surface staining and OCT4 (Invitrogen, 1:300) and KI67 (BD,
1:100) for intracellular staining. Secondary antibodies used were
goat anti-mouse IgG Alexa Fluor – 488 (Invitrogen, 1:300) and
anti-mouse IgG-PE (1:300, Miltenyi Biotec).
Quantitative Real Time (qRT)-PCR
At different time points of differentiation, RNA samples were
extracted by using High Pure RNA Isolation Kit (Roche) and
converted into complementary cDNA with Transcriptor High
Fidelity cDNA Synthesis Kit (Roche). Real-time quantitative PCR
(qPCR) was performed using the StepOneTM or the ViiATM 7 RT-
PCR Systems (Applied BioSystems). Taqman R© Gene Expression
Assays (20X, Applied Biosystems) were selected for NANOG,
PAX6, TBR1, DLX2, NKX2.1, LHX6, FOXG1 and GAPDH.
DLL1, HES5, PARVALBUMIN (PV), VGLUT1 and GAPDH
analysis were performed using the SYBR Green Master Mix
(Nzytech). The results were analyzed with the StepOneTM or
the QuantStudioTM RT-PCR Software. All PCR reactions were
done in duplicate or triplicate and then normalized to the
housekeeping gene GAPDH. The fold change was calculated
using the 21Ct method and in some graphical results it was
calculated relatively to the control condition levels obtained.
The representative heatmaps were generated using the web tool
Clustvis (Metsalu and Vilo, 2015).
RNA in situ Hybridization
The probes were generated by using a template cDNA,
amplified by PCR, with the reverse primers containing the T7
site: DLL1-fw (TGTGCCTCAAGCACTACCAG) rv(+T7) (TA
ATACGACTCACTATAGGGATGCTGCTCATCACATCCAG);
HES5-fw (ACGCAGATGAAGCTGCTGTA) rv(+T7) (TA
ATACGACTCACTATAGGGGGCCCTGAAGAAAGTCCTCT).
The PCR products were gel-purified using the NZYGelpure
kit (NZYTech) and used for reverse transcription with T7
polymerase (Agilent Technologies), DIG-dNTPs (Sigma),
and RNase inhibitor. The RNA was precipitated with EtOH
and NaOAC3 at 20◦C overnight, centrifuged 30 min at
13.000 g, and then washed with 70% EtOH, dried, and
resuspended in nuclease-free H2O with 10mM of EDTA
(stored at 20◦C until use).
The organoids were fixed in 4% PFA (w/v) during 1 h at 4◦C.
Fresh cryosections (12 µm) were incubated with 10 nM FISH
probes, overnight, at 65◦C in hybridization buffer, containing 1x
salts, 10% dextran sulfate, 1 mg/mL rRNA, 1x Denhardt’s and 50%
of deionized formamide (Sigma). After hybridization, the cells
were washed twice, for 30 min at 65◦C, using a washing buffer
[10% formamide (Sigma) in 2× SSC] and then washed at RT with
TBST. The slices were then blocked using TBST with 2% (v/v)
blocking reagent (Roche) and 20% (v/v) heat inactivated sheep
serum (Sigma) for 1h at RT. The slices were then stained with
antibody anti-DIG (Abcam) diluted into TBST, 2% (v/v) blocking
reagent, 1% sheep serum and left to incubate overnight, at 4◦C.
After incubation, slices were washed four times with TBST.
Afterward, organoid slices were incubated twice during 10 min in
0.4M NaCl, Tris 0.1M (pH8). The incubation was then performed
with Fast-red tablets substrate (Sigma) diluted in 0.4M NaCl, Tris
0.1M (pH8) for 1–3 h in the dark until the visible spots appear,
and then the reaction was stopped with PTW [PBS + 0.1% (v/v)
Tween-20]. Immunofluorescence staining was then performed.
Images were acquired using Zeiss LSM 710 Confocal Laser Point-
Scanning Microscopes and processed in ZEN 2.3 blue edition
software (Zeiss).
Single Cell Calcium Imaging (SCCI)
The organoids used in calcium imaging recordings were
first dissociated gently with accutase, 4–5 days before the
recordings, and replated into matrigel-coated 8-well chambers
Lab-TekTM Chamber Slide (ThermoFisher Scientific). Before
the experiments, cells were loaded with 5 µM Fura-2 AM
(Invitrogen) in Krebs solution (132 mM NaCl, 4 mM KCl, 1.4 mM
MgCl2, 2.5 mM CaCl2, 6 mM glucose, 10 mM HEPES, pH
7.4) for 45 min at 37◦C in an incubator with 5% CO2 and
95% atmospheric air (Silva et al., 2020). Cells were washed in
Krebs solution and then mounted on an inverted microscope
with epifluorescence optics (Axiovert 135TV, Zeiss). Cells were
continuously perfused with Krebs solution and stimulated by
applying high-potassium Krebs solution (containing 50 mM
KCl, isosmotic substitution with NaCl) or 100 µM histamine.
The time course of SCCI experiments was the following: 300 s
baseline, stimulation with KCl from 300 to 420 s, KCl washout
from 420 to 600 s, stimulation with histamine from 600 to
720 s and histamine washout from 720 to 900 s recordings.
Following that, Histamine/KCl ratios were calculated using
the corresponding peak values given by normalized ratios of
fluorescence at 340/380 nm from image pairs acquired every
200 ms by exciting the cells at 340 and 380 nm. Mature neurons
typically depict ratios below 0.8 (Agasse et al., 2008; Bernardino
et al., 2013). Excitation wavelengths were changed through a
high-speed switcher (Lambda DG4, Sutter Instrument, Novato,
CA, United States). The emission fluorescence was recorded
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at 510 nm by a cooled CCD camera (Photometrics CoolSNAP
fx). Images were processed and analyzed using the software
MetaFluor (Universal Imaging, West Chester, PA, United States).
Regions of interest were defined randomly and manually over
the cell profile.
Patch-Clamp Recordings
Organoids were first dissociated gently with accutase, 4–
5 days before the recordings, and replated into glass cover-
slips previously coated with matrigel. Whole-cell patch-clamp
recordings were visualized with an upright microscope (Zeiss
Axioskop 2FS) equipped with differential interference contrast
optics using a Zeiss AxioCam MRm camera and a x40 IR-
Achroplan objective. During recordings, cells were continuously
superfused with artificial cerebrospinal fluid (aCSF) containing
124 mM NaCl, 3 mM KCl, 1.2 mM NaH2PO4, 25 mM NaHCO3,
2 mM CaCl2, 1 mM MgSO4, and 10 mM glucose, which
was continuously gassed with 95%O2/5%CO2. Recordings were
performed at room temperature in current-clamp or voltage-
clamp mode [holding potential (Vh) = −70 mV] with an
Axopatch 200B (Axon Instruments) amplifier (Dias et al.,
2014). The step-and-hold stimulation protocol included 11
steps of 500 ms long depolarization pulses. The first injection
current was −25 pA and the subsequent ones increased
progressively until 225 pA.
Action potential activity was recorded using patch pipettes
(4–9 M resistance) pulled from borosilicate glass capillaries
(1.5 mm outer diameter, 0.86 mm inner diameter, Harvard
Apparatus, Holliston, MA, United States) with a PC-10 Puller
(Narishige Group, London, United Kingdom) filled with an
internal solution containing 125 mM K-gluconate, 11 mM KCl,
0.1 mM CaCl2, 2 mM MgCl2, 1 mM EGTA, 10 mM HEPES,
2 mM MgATP, 0.3 mM NaGTP, and 10 mM phosphocreatine,
pH 7.3, adjusted with 1 M NaOH, 280–290 mOsm. Acquired
signals were filtered using an in-built, 2-kHz, three-pole Bessel
filter, and data were digitized at 5 kHz under control of the
pCLAMP 11 software programs (Molecular Devices, San José,
CA, United States). The junction potential was not compensated
for, and offset potentials were nulled before gigaseal formation.
The resting membrane potential was measured immediately
after establishing whole cell configuration and the junction
potential of the electrode was considered (−12 mV). Firing
patterns of neurons were determined in current-clamp mode
immediately after achieving whole-cell configuration by a series
of hyperpolarizing and depolarizing steps of current injection
(1 s). In the voltage-clamp mode, spontaneous miniature
postsynaptic currents were recorded in a CSF solution during
5 min. Analysis of the amplitude and half-peak within were
performed off line using the Clampfit 11 software. AP velocity
(dV/dt) in a train of AP firing near threshold was represented
from the first derivate of the first AP generated.
Lentiviral Transfection for Derivation of
GFP+ hiPSCs Lines
HEK 293T cells were used for lentiviral production, followed
by concentration by ultra-centrifugation. Briefly, a second
generation packaging system composed of three plasmids
(transfer vector with expression construct LV-GFP, the packaging
plasmid psPAX2, and the envelope protein expression plasmid
pMD2.G – pMD2.G, a gift from Didier Trono (Addgene plasmid
# 122591; RRID: Addgene_12259), was mixed in a ratio of 2:1:1
in DMEM (Thermofisher Scientific) and Fugene6 transfection
reagent (Roche) and 293T cells were transfected during 4 h
to overnight. The supernatant from the transfected plate was
collected every 24 h in serum-free conditions and concentrated
by ultracentrifugation (Beckman XL-90) at 90.000 rpm for 2 h
at 4◦C. The concentrated viral solution was passed through a
0.45 µm low-protein binding filter and aliquots were used to
transfect the hiPSCs lines. The cell lines F002.1A.13, Gibco R©
iPSC6.2 and EMC24i/R2 (C6) were successfully transfected, by
first incubating the cells in a 24-well plate during 30 min
at 37◦C with E8 medium, 10 µM ROCKi and 5 µg/mL of
Polybreme (Sigma). Then, LV-GFP previously dissolved in E8 was
added dropwise and the cells were incubated during 1 h30 min.
Culture medium was then changed daily. After cell growth and
expansion, FACS sorting of GFP+ cells was performed using
BD FACSAriaTM III (BD Biosciences-US) in order to obtain
pure populations.
Statistical Analysis
The data were expressed as mean of ± standard error of
mean (SEM) from at least three independent n experimental
replicates/differentiations, as n number of organoids analyzed or
n neurons (SCCI and patch-clamp recordings). Mean differences
between control cell lines and RTT lines were evaluated
by two-tailed unpaired and non-parametric t-test. Statistical
processing was performed using Microsoft Excel and GraphPad
Prism Software. Statistical significance level was set for (∗)
p-values < 0.05; (∗∗) p-values < 0.01; (∗∗∗) p-values < 0.001.
The statistical details of experiments are also present in
the figure legends.
Data Availability
The authors declare that all raw data presented in all the figures
of the manuscripts that support the findings of this study are
available from the corresponding author upon request.
RESULTS
MeCP2:R255X Dorsal Forebrain
Organoids Reveal Premature Formation
of Cortical Plate Neurons
Glutamatergic pyramidal neurons arise mainly from progenitors
in the dorsal region of the forebrain (the pallium), specifically
from radial glial cells (RGs), found in the VZ, and from
outer radial glial cells (oRGs) and intermediate progenitors
(IPs), found in the subventricular zone (SVZ) (Lui et al.,
2011). For modeling RTT-derived alterations in the process of
neurogenesis in the dorsal forebrain, we engineered organoids
1http://n2t.net/addgene:12259
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resembling this brain region. Dorsal organoids were generated
from four distinct female and male healthy control hiPSCs and
two patient-specific RTT hiPSC lines (female MeCP2:R255X
and male MeCP2:Q83X). It is known that, in females, random
inactivation of the X-chromosome occurs during development
(Balachandar et al., 2016). Therefore, as MeCP2 gene is located
in the long arm of the X chromosome, RTT female patients
are characterized by the presence of somatic mosaicism. Since
female hiPSCs retain an inactive X-chromosome in a non-
random pattern (Tchieu et al., 2010), it was possible to obtain
an isogenic control (IC-MeCP2:R255X) from a distinct clone
isolated upon reprogramming of the mosaic female cell line
(Supplementary Figure 1.1A). Upon differentiation, IC cells
exhibited only the non-mutated MeCP2 active X-chromosome.
The presence/absence of the mutations was confirmed by
Sanger sequencing of gDNA and cDNA (Supplementary
Figure 1.1B). The pluripotent phenotype of the IC and female
and male RTT hiPSC lines was confirmed by flow cytometry
(Supplementary Figure 1.1C).
The dorsal forebrain organoids were generated according
to the dual-SMAD inhibition protocol and cultured until
day 41 by adapting previously described methodologies (Qian
et al., 2016) (Figure 1A). As an important modification,
hiPSCs were cultured in AggrewellTM 800 plates during
the 5 days of neural induction (Miranda et al., 2015,
2016, 2018). This strategy allowed the generation of size-
controlled aggregates, with a narrow size-distribution (diameter
250–300 µm) (Supplementary Figure 1.1D), allowing a
more homogeneous feeding of soluble factors across the
aggregate. At day 13 of dorsal induction, histological analysis
of organoid cryosections, revealed the presence of cells
expressing the forebrain specific progenitor marker OTX1/2
in all dorsal organoids (see Supplementary Figure 1.1E).
Moreover, the formation of SOX2+/NCAD+ neural rosette-like
structures, resembling the neural tube, was also observed (see
Supplementary Figure 1.1F). All dorsal organoids revealed the
presence of SOX2+ progenitor cells, resembling the proliferative
regions of the human VZ. In addition, the rosette structures
exhibited the cadherins junction marker N-CAD, located at the
luminal side (see Supplementary Figure 1.1F).
To further confirm the dorsal identity of these organoids,
we examined the mRNA expression levels of dorsal, ventral
and pluripotency markers at day 41 of differentiation by qRT-
PCR (Figures 1B,C). Expression of FOXG1 was observed
in all organoids, confirming their forebrain identity. The
ventral layer markers, DLX2, NKX2.1 and LHX6, and the
pluripotency marker NANOG, were almost undetectable. It
was also detected a high expression of the neural progenitor
dorsal-cortical marker PAX6, and of TBR1, a marker typically
expressed in neurons of deep cortical layer VI (Hevner et al.,
2001). No significant differences were found when comparing
the mRNA levels of the male-RTT organoids with the ones
of the control organoids. For this reason, we focused our
subsequent analyzes on the RTT female cell line, the respective
IC and the healthy-controls. Interestingly, female RTT dorsal
organoids exhibited a statistically significant higher expression
of TBR1 (see Figure 1Ei) when compared with the IC and
healthy-control dorsal organoids, and a statistically significant
lower expression of PAX6 (see Supplementary Figure 1.2A)
when compared to the healthy-control organoids. A specific
oRG cells marker, HOPX, was used to verify the presence of
a prominent oRGC-like population (Qian et al., 2016). On
Supplementary Figure 1.2B, by immunocytochemistry, it was
possible to observe the presence of that progenitor layer, which
is characteristic of human cortical development. However, a
narrower expression pattern was detected for the Rett female cell
line organoids in comparison to control organoids. Moreover,
immunocytochemistry analysis of organoid sections showed that
control organoids developed a well-defined TBR2+ IP cell region,
confirming the presence of a SVZ layer, an important hallmark
of human cerebral cortex development. Conversely, female RTT
dorsal organoids lacked SVZ formation, as observed by the
absence of TBR2+/SOX2+ cells (Supplementary Figure 1.2C).
In line with this observation, quantification of the number of
TBR2+ cell nuclei confirmed the presence of these progenitor
cells in healthy-control (16 ± 4%) and IC (18 ± 2%) organoids
and the almost complete absence of these cells in female RTT
organoids (Supplementary Figure 1.2D). We further detected
that TBR1 was mainly expressed superficially to the progenitor
SOX2+ VZ-like layer (Figure 1D). Importantly, TBR1 protein
was expressed in a higher percentage of cells in the female RTT
organoids (41 ± 5%), when compared with the healthy-control
(21 ± 3%) and with the IC (22 ± 4%) organoids (Figure 1Eii).
Furthermore, RTT female organoids exhibited the presence of
CTIP2+ cells, indicating the specification of a deep cortical plate
layer, which at this time-point is not yet observed in healthy-
control and IC organoids (Figure 1D).
Overall, dorsal forebrain organoids derived from the RTT
mutant female hiPSCs revealed a higher expression and
premature formation of newborn deep-layer cortical neurons, in
parallel with a depletion of IP cells and a decrease in the number
of oRG cells. These results suggest that for the hiPSC lines
exhibiting the MeCP2:R255X mutation, molecular and structural
alterations start to occur early in development, during the process
of formation of cortical layers in dorsal forebrain consistent with
a premature neuronal differentiation process.
Premature Differentiation in
MeCP2:R255X Dorsal Organoids
Considering the imbalance in the neurogenesis process revealed
by the female RTT dorsal forebrain organoids, we next
questioned which neurodevelopmental processes could be
responsible and/or affected by this phenomenon. Quantitative
analysis of the thickness of the early born TUJ1+ neuronal
layer (schematic view in Figure 2A), localized above the SOX2+
VZ layer apical region, revealed a significant increase in RTT
female organoids (39.03± 3.35 µm) in comparison with healthy-
control (27.71 ± 2.87 µm) and IC organoids (24.22 ± 2.10 µm)
(Figures 2B,C). Moreover, flow cytometry analysis revealed a
significantly lower percentage of KI67+ proliferative cells in
female RTT dorsal organoids (24 ± 1%) in comparison with the
control (37 ± 4%) and the IC organoids (35 ± 8%) (Figure 2E
and Supplementary Figure 2C). In agreement with these results,
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FIGURE 1 | Dorsal forebrain organoids derived from RTT-specific hiPSCs reveal a premature formation of the cortical plate. (A) Schematic overview of the protocol
for dorsal forebrain organoid development until day 41 of differentiation. (B) Schematic overview of the two forebrain regions of the mammalian cortex presenting the
characteristic markers/populations for dorsal and ventral regions. (C) Transcriptional profile of dorsal forebrain organoids at day 41 of differentiation. Quantitative
RT-PCR analysis of the pluripotency marker NANOG, the forebrain ventral characteristic markers LHX6, NKX2.1 and DLX2, the generic forebrain marker FOXG1 and
the dorsal characteristic markers PAX6 and TBR1. All values were normalized and relative to GAPDH. Raw minimum (min) and raw maximum (max) values were
taken as a reference for heatmap representation. (n = independent experiments. Control n = 10; IC n = 5; MeCP2:R255X n = 4; MeCP2:Q83X n = 4).
(D) Immunofluorescence characterization of dorsal organoids at day 41. Representative images of dorsal organoid sections were stained against PAX6, NESTIN and
SOX2 (neural progenitor markers), TBR1 (marker for new-born neurons of the deep cortical layer VI), and CTIP2 (marker for neurons of deep cortical layer V). Scale
bars, 50 µm. (E) (i) Relative mRNA levels of TBR1 on dorsal organoids at day 41 of differentiation already represented on the heatmap (C). mRNA levels relative to
GAPDH and normalized to control condition. n = independent experiments; Control n = 10; WT-MeCP2:R255X n = 5; MeCP2:R255X n = 4; MeCP2:Q83X n = 4.
For all graphics depicted, Student’s t-test (two-tailed) statistics, was applied *p < 0.05, **p < 0.01, ***p < 0.001; error bars represent SEM. (ii)
Immunocytochemistry quantification of the percentage (%) of cells expressing TBR1 normalized to the total number of cells stained with DAPI. TBR1: Control n = 3
(12 organoids); IC-MeCP2:R255X n = 3 (8 organoids); MeCP2:R255X n = 3 (10 organoids). n = independent experiments. For all graphics depicted, Student’s
t-test (two-tailed) statistics, was applied *p < 0.05, **p < 0.01, ***p < 0.001; error bars represent SEM.
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FIGURE 2 | Altered proliferation pattern and dynamics of expression of Notch signaling operands HES5 and DLL1 during differentiation of RTT female
patient-derived dorsal organoids. (A) Schematic representation of SOX2+ ventricular zone (VZ) and TUJ1+ neuronal layer measurement in cortical structures. For
each cortical structure, three measurements were taken for the post-mitotic neuronal zone. (B) Representative images of the VZ delineated by white dashes and the
neuronal layer containing TUJ1+ cells at day 41. Scale bars, 50 µm. (C) Mean value of the thicknesses of the neuronal zone layer (µm). Three measurements were
performed for each zone in each structure. (n = independent experiments; healthy control: n = 10 and 19 cortical structures from at least 10 individual organoids;
IC-MeCP2:R255X: n = 5 and 14 cortical structures from at least 10 individual organoids; MeCP2:R255X: n = 4 and 25 cortical structures from at least 10 individual
organoids). (D) Representative immunofluorescence images of KI67 proliferative marker and TUJ1+ neuronal marker at day 41. Scale bars, 50 µm. (E) Quantification
of the% of KI67+ cells as determined by flow cytometry analysis. (F) qRT-PCR analysis of the expression of (i) the Notch target and the transcription repressor of
proneuronal genes HES5 (days 41) and (ii) the Notch ligand DLL1 (day 41). mRNA levels relative to GAPDH and normalized to the control condition.
(n = independent experiments; WT: n = 6; IC-MeCP2:R255X: n = 4; MeCP2:R255X: n = 3). (G) Representative images of in situ hybridization of (i) HES5 and (ii)
DLL1 as RNA probes and their co-localization with TUJ1 performed by Immunofluorescence. Scale bars, 50 µm. (H) Representative immunofluorescence images of
HES5 staining and the co-localization with the progenitor marker SOX2. Scale bars, 10 µm. For all graphics depicted, Student’s t-test (two-tailed) statistics, was
applied *p < 0.05, **p < 0.01, ***p < 0.001; error bars represent SEM.
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histological sections of dorsal organoids revealed the presence
of KI67+ cells in control and IC organoids, mainly located near
the apical surface of VZ-area, whereas a lower number of these
cells were observed in RTT organoids (Figure 2D). We also
examined cell death by apoptosis as a potential mechanism for the
undetectable IP cell pool in female RTT organoids by quantifying
the cells expressing cleaved (active) caspase-3 (CAS3). However,
this analysis revealed the presence of rare apoptotic cells, at
day 41, for all the organoids (Supplementary Figures 2A,B).
Altogether, these results suggest a possible imbalance in the
generation of differentiating neurons in RTT organoids, with
premature exhaustion of proliferating progenitor pool and
increase in the number of newborn neurons.
Notch signaling regulates the generation and maintenance of
several cell types, including cells from the SVZ, outer SVZ and
cortical plate (Kageyama et al., 2008). To elucidate the molecular
mechanisms by which MeCP2:R255X mutation may influence
the premature transition toward neuronal differentiation, we
examined mRNA levels at day 41 of the Notch ligand Deltalike1
(DLL1) and of the Hes family basic helix-loop-helix factor 5
(HES5), a direct downstream target of Notch. The levels of HES5
mRNA were found significantly increased for the female RTT
dorsal organoids when compared with the healthy-controls, and
increased in comparison to the IC organoids (Figure 2Fi). On
the other hand, it was observed a significant decrease in the
expression of DLL1 in MeCP2:R255X organoids (Figure 2Fii).
The premature formation of post-mitotic neurons can be related
with the dynamics of gene expression of Notch operands that
regulates, both cell-autonomously and cell-non-autonomously,
the time-transitions of progenitor cells into differentiated neural
cells (Kageyama et al., 2008). Thus, for better understanding
the levels of gene expression of Notch signaling ligands and
targets, we performed in situ hybridizations at day 41, co-
localized with immunostaining for TUJ1+ neurons and SOX2+
progenitors. In healthy-controls and IC organoids the expression
of the Notch ligand DLL1 is observed in the TUJ1+ neuronal
cell layer, and also in scattered progenitors (Figure 2Gii). On
the other hand, in female RTT organoids, DLL1 expression
is reduced, being expressed exclusively in TUJ1+ post-mitotic
neurons (Figure 2Gii). Furthermore, HES5 expression is found
only in PAX6+ progenitor cells (Supplementary Figure 2D), and
not in the post-mitotic TUJ1+ neurons (Figure 2Gi), as it would
be expected. Moreover, the expression of the HES5 protein is
also higher in the female RTT organoids when compared with
controls (Figure 2H). Altogether, these results suggest a possible
deregulation of the Notch signaling in MeCP2:R255X organoids,
during the stage of deep cortical layer formation.
MeCP2:R255X Neurons Exhibit Altered
Intracellular Calcium Dynamics and
Functional Neural Network
The functionality of mature neurons derived from dorsal
organoids, generated from healthy-controls, IC and RTT female
hiPSC lines, was characterized using single cell calcium imaging
(SCCI) and whole-cell patch-clamp analysis (Silva et al., 2020).
SCCI analysis was used for functional discrimination of the
organoid populations in terms of expression/sensitivity of
voltage sensitive calcium channels (VSCC) and for testing their
responsiveness to depolarization. Functional recordings of SCCI
were performed at days 44–47 and at days 64–67, during
which time cultures were maintained in serum-free BrainPhysTM
medium (Satir et al., 2020) (Supplementary Figure 3A). Dorsal
organoids were preloaded with the calcium indicator Fura-2AM
on the day of the experiment. Cells were then exposed to 50 mM
of KCL, which in excitable cells, like neurons, leads to the
opening of VSCCs and a massive influx of calcium, followed
by stimulation with Histamine, which leads to an increase in
intracellular calcium concentration in stem/progenitor cells due
to the activation of H1 receptor (Molina-Hernández and Velasco,
2008). Figure 3A shows representative peaks of SCCI for replated
organoids obtained during KCL and Histamine stimulation.
Histamine/KCl ratios for mature neurons are typically below 0.8
(Agasse et al., 2008; Bernardino et al., 2013). Between days 44–
47, female RTT organoids contained 74 ± 7% of cells behaving
like neurons, while the mean percentage of neurons present in
healthy-controls and IC organoids was 48 ± 7% and 48 ± 8%,
respectively. At later time points, between days 64 and 67, an
expected maturation was observed in healthy-controls and IC
organoids, with 62 ± 11% and 57 ± 8% of cells presenting
a neuron-like response, respectively (Figure 3B). However,
MeCP2:R255X organoids displayed a significant decrease in the
percentage of cells with neuron-like response in comparison
with days 44–47 of differentiation, and also in comparison with
control organoids. Immunostaining analysis revealed that, on
days 44–47, female RTT organoids exhibited denser TUJ1+
neuronal networks compared with IC and healthy controls
and on days 64–67, MeCP2:R255X neurons showed punctate
MAP2 staining (Figure 3A). Nevertheless, from days 44–47 to
64–67, this culture showed a significant increase of cells not
responsive to KCL neither to Histamine (Figure 3C). Thus,
altogether, these results indicate that prematurely differentiated
MeCP2:R255X neurons might not be able to complete their
functional maturation.
Functional maturation of dorsal organoids was also assessed
by whole-cell patch-clamp, at days 44–47. For the healthy-control
organoids, a total of 8 cells were analyzed, with 50% of the
cells being able to respond to a continuous current injection,
demonstrating a typical repetitive neuronal firing action potential
(AP) (Figures 3D,E). For the IC organoids, from a total of
9 cells analyzed, 88% presented a typical firing AP. However,
for the MeCP2:R255X organoids, from a total of 11 cells, 45%
exhibited an atypical firing AP, with a decreased firing frequency
(Supplementary Figure 3Bi) and with most of the neurons
presenting an abortive-like AP (Figures 3D,E). Overall, the
majority of control neurons exhibited more mature AP firing
properties, presenting a faster and consistent AP velocity near
threshold (dV/dt), while MeCP2:R255X neurons were more
immature, presenting a reduced AP velocity (Figure 3G).
Additionally, from the analysis of spiking cells, a significant
reduction in AP amplitude was observed for MeCP2:R255X
organoids when compared with IC, and also when compared
with the healthy-control neurons (Figure 3Fi). As shown in
Figure 3Fii, the half-peak width of female RTT neurons was
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FIGURE 3 | Functional analysis of dorsal forebrain organoids during maturation. (A–C) Single cell calcium imaging (SCCI) of dorsal organoids. (A) Representative
fluorescence ratio profiles (left) of individual cells on days 44–47 and 64–67. Representative immunofluorescence images (right) for the neural progenitor marker
PAX6 and for the new-born neuronal marker TUJ1 on days 44–47 and for the mature neuronal marker MAP2 on days 64–67. Immunofluorescence analysis was
performed by using the cultures previously analyzed by SCCI. Scale bar 50 µm; (B) Percentage of cells displaying a Histamine/KCl ratio below 0.8, which is
indicative of the% of cells functionally behaving like neurons. (C) Percentage of cells that neither respond to histamine neither to KCL. Total number of cells analyzed
(Continued)
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FIGURE 3 | Continued
(n = independent experiments): Control: n = 6 with 618 cells analyzed at day 44–47 and 407 cells analyzed at days 64–67; IC-MeCP2:R255X: n = 4 with 358 cells
analyzed at days 44–47 and 271 cells analyzed at days 64–67; MeCP2:R255X: n = 3 with 461 cells analyzed at day 44–47 and 415 analyzed at days 64–67. (D–G)
Patch-clamp recordings of single cells at day 47. (D) Percentage of cells depicting at least one firing action potential (AP). (E) Representative traces of firing
responses evoked under current-clamp mode by injection of a 500 ms current pulse [–25 (i) to +275 pA in 25-pA increments (ii,iii) from an initial holding potential
(Vh) of –70 mV]. Scale bars correspond to 50 pA and 200 ms. (F) (i) AP amplitudes measured from the first AP depicted; (ii) Half-peak width measured from the first
AP depicted. (G) Representative views of the AP velocity firing near threshold (dV/dt). Scale bars correspond to 20 pA and 200 ms. (H) Representative recordings of
spontaneous postsynaptic currents. Scale bars correspond to 10 pA and 2000 ms. (I) (i) Representative immunofluorescence images of 4–5 days-old replated
organoid cultures stained for VGLUT1 and MAP2. Scale bar 20 µm. Representative amplification of neurons showing VGLUT1 puncta on MAP2 neurites. Scale bar
10 µm. (ii) Normalized density of VGLUT1 pre-synaptic puncta. n = independent experiments; Control: n = 7; IC-MeCP2:R255X: n = 4; MeCP2:R255X: n = 6. (J)
(i) Immunofluorescence images of PSD95 and SYNP1. The overlap between PSD95 and SYNP1 (yellow) indicate sites of synaptogenesis. Scale bar 10 µm. (ii)
PSD95/SYNP1 ratio measured from immunofluorescence images. For all graphics depicted, Student’s t-test (two-tailed) statistics was applied: *p < 0.05,
**p < 0.01, ***p < 0.001; error bars represent SEM.
significantly larger when compared with that of the control
neurons. In spiking cells, the resting membrane potential values
were similar for all the neuronal cells analyzed (Supplementary
Figure 3Bii). At later time points of maturation, by day 81,
healthy-control neurons presented an increase in spiking activity,
whereas for the MeCP2:R255X neurons, none of the 8 cells
analyzed presented firing AP (see Supplementary Figures 3C,D).
Moreover, spontaneous currents, which provide an indication
of the presence of functional neurotransmitter receptors, were
also recorded. The representative traces indicate the absence
of synaptic transmission for MeCP2:R255X organoids and the
establishment of some neuronal functional connections for both
the control and the IC-derived neurons (Figure 3H).
Neurons from dorsal organoids were also characterized
concerning the expressing of characteristic markers of mature
neurons. A higher mRNA expression of the vesicular glutamate
transporter marker VGLUT1 was observed at day 81 in
MeCP2:R255X organoids when compared with all control
neurons (Supplementary Figure 3E), with VGLUT1 puncta
being observed in MAP2+ dendrites (Figure 3Ii). However, a
reduction in the density of VGLUT1 puncta was observed in
MeCP2:R255X organoids when compared with control and IC
organoids (Figure 3Iii).
Furthermore, cells were stained for the pre-synaptic protein
synapsin-1, SYNP1, and the post-synaptic-protein PSD95 and
the PSD95/SYNP1 ratio was found to be significantly lower
for RTT organoids, which could indicate a decreased synaptic
density (Figure 3Jii). Additionally, the co-localization of these
two indicators of mature excitatory synapses was observed in
healthy-control and IC organoids but not in female RTT neurons
(Figure 3Ji). Interestingly, we observed the presence of GFAP+
astrocytes in close association with neurons in all the dorsal
organoids at day 81 (Supplementary Figure 3F).
Ca2+ diffusion and synaptic transmission have been
correlated with spine morphology, which changes during
developmental maturation (Risher et al., 2014). As MeCP2
has been proved to be essential for dendritic spine formation,
the spine head width and neck length of neurons in dorsal
organoids were measured at days 47 and 67. The proportion
of mushroom and stubby spines, which increases with spine
complexity and maturation, was found to decrease along the
differentiation for the female RTT organoids, which instead
presented an increase in the number of filopodia and long thin
spine types. Conversely, an increased number of more mature
branched spines were observed in all control neurons (see
Supplementary Figures 3G,H).
Taken together, these results indicate that healthy-control and
IC dorsal organoids supported the generation of functional
neurons, by establishing neuronal connectivity, while
MeCP2:R255X organoids present defects in neuronal maturation.
Impaired Interneuron Migration in RTT
Forebrain Organoids
Ventral cortical organoids were generated from all hiPSC lines
and cultured until day 81 (Figure 4A). Neural induction was
performed by dual-SMAD inhibition followed by activation of
the sonic hedgehog (SHH)-signaling pathway, as previously
described (Bagley et al., 2017). The ventral identity of organoids
was assessed by qRT-PCR analysis at day 41 (Figure 4B).
The mRNA expression of typical dorsal markers, TBR1 and
PAX6, and of the pluripotency marker NANOG was almost
undetectable. The ventral marker DLX2 was expressed at low
levels, accompanied with high expression of the forebrain marker
FOXG1 (Figure 4B). qRT-PCR was also used to characterize
the expression of the different interneuron progenitor’s subtypes
that are produced in specific subregions of the ganglionic
eminence (GE) zone of the ventral forebrain (Gelman et al.,
2012). NKX2.1, which is expressed in the MGE (Sandberg
et al., 2016) and from which several ventral interneuron
subtypes are generated, was found highly expressed in our
ventral organoids. The mRNA levels of LHX6, expressed in
a sub-region of MGE that also originates ventral interneuron
subtypes, was also found increased in ventral organoids, with
no significant differences being found between controls and
RTT organoids (Figure 4B). Importantly, at day 41, RTT
cells showed a significant decrease in mRNA levels for the
NKX2.1 gene when compared with the healthy control cells,
and a tendency for a decreased expression of this marker in
comparison with the IC organoids (Supplementary Figure 4A).
Again, no significant differences were observed between male
ventral RTT organoids and the respective healthy controls, so we
decided to proceed with a detailed analysis for the RTT female
cell line.
MGE-derived post-mitotic interneurons migrate toward
the dorsal cortex region, integrating into an appropriate
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FIGURE 4 | Ventral and fused forebrain organoids derived from the female patient-specific RTT hiPSC line reveal impairments in cell migration. (A) Schematic
overview of the protocol for ventral patterning of hiPSCs until day 81 of culture. (B) Transcription profile of ventral forebrain organoids at day 41 of differentiation.
Quantitative RT-PCR analysis for the pluripotency marker NANOG, the forebrain ventral markers LHX6, NKX2.1 and DLX2, the generic forebrain marker FOXG1 and
the dorsal markers PAX6 and TBR1. All values were normalized to GAPDH. Raw minimum (min) and raw maximum (max) values were taken as a reference for the
heatmap representation. n = independent experiments; Control: n = 11; IC-MeCP2:R255X: n = 4; MeCP2:R255X: n = 4; MeCP2:Q83X: n = 5. (C) (i)
Immunofluorescence images of replated ventral organoids stained for DCX and TUJ1 (images used for DCX count). Scale bar 50 µm (ii) Percentage of DCX+
immature migrating interneurons relative to total DAPI+ nuclei. n = independent experiments; Control: n = 3 (5 images); IC-MeCP2:R255X: n = 3 (9 images);
MeCP2:R255X: n = 3 (11 images). (D) Immunofluorescence staining of replated ventral organoids for markers of MGE-derived GABAergic neurons, PV and SOM,
with the mature neuronal marker NEUN. Scale bar 10 µm. (E) (i) Fused organoids (GFP− dorsal organoids fused with GFP+ ventral organoids) stained with DAPI.
Images were divided into 7 segments, the % of GFP+ cells was analyzed in each segment and normalized to the DAPI+ nuclei. Scale bar 50 µm (ii) Migration
distance for GFP+ cells in MeCP2:R255X derived-fused organoids. Control (9 organoids); MeCP2:R255X (9 organoids). For all graphics depicted, Student’s t-test
(two-tailed) statistics, was applied *p < 0.05, **p < 0.01; error bars represent SEM.
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neuronal circuit (Zimmer-bensch, 2018). To investigate potential
alterations to this process in female RTT ventral organoids,
the expression of DCX, a marker for immature migrating
interneurons, was quantified at day 41. Interestingly, the
expression levels for DCX were significantly decreased in
the ventral female RTT organoids, when compared with all
control organoids (Figures 4Ci,ii). It is also known that
the large majority of neurons produced in the MGE region
express parvalbumin (PV) and somatostatin (SOM) (Gelman
et al., 2012). The presence of SOM+ and PV+ interneurons
at day 81 was indeed detected in all our ventral organoids
(Figure 4D). The possible alteration in the generation of
NKX2.1+ interneuron progenitors and the observed DCX
decrease could consequently induce changes in the interneuron
migratory dynamics. To evaluate this hypothesis, we employed
a more complex system, obtained by assembling organoids of
dorsal and ventral forebrain identities (Bagley et al., 2017; Xiang
et al., 2017) (Supplementary Figure 4B). Upon characterization
of the fused organoids at day 41, we found the same molecular
alterations previously observed in independently generated
dorsal and ventral organoids regarding the expression of TBR1
and NKX2.1 (see Supplementary Figures 4Ci,ii). To follow the
process of interneuron migration, the MECP2:R255X and two
control cell lines were induced to express GFP by lentiviral
transfection. To test whether interneurons from the ventral
region could migrate, the ventral patterning protocol using
the GFP+ reporter line and the dorsal patterning protocol
using the GFP− cell line were employed. The assembly
of both organoid types was then performed at day 13,
with merged organoids being observed already by day 14
(Supplementary Figure 4D). Finally, we analyzed migrating
GFP+ cells at day 41 in organoid cryosections. Interestingly, it
could be observed that the GFP+ ventral cells in MECP2:R255X
fused organoids migrated shorter distances than GFP+ cells
from healthy-control hiPSCs (Figures 4Ei,ii). These fused
organoids derived from the controls and MECP2:R255X lines
were later characterized, at day 81, by immunostaining. It
was found that they contained cells expressing MAP2 and
the astrocyte marker GFAP (Supplementary Figure 4Ei), as
well as the mature glutamatergic pyramidal neuronal marker
VGLUT1 and the GABAergic interneuron marker VGAT
(Supplementary Figure 4Eii.).
DISCUSSION
Herein, hiPSCs derived from RTT patients were used to
model the development of the human forebrain by using
region-specific and assembled forebrain organoids. Several
aspects were studied, including the formation of the
neuroepithelial layers, their intrinsic cellular diversity and
the neuronal network functionality. In contrast with the
majority of MeCP2 gene-KO mice and hiPSCs-based RTT
models, we developed 3D models presenting phenotypical
characteristics of RTT caused by the female MeCP2:R255X
mutation and the male MeCP2:Q83X mutation, present in the
human population.
First, we developed organoids exhibiting the main
molecular developing features of the dorsal forebrain domain.
MeCP2:R255X dorsal organoids displayed an increase in
gene and protein expression for the TBR1 marker, present in
glutamatergic post-mitotic neurons in the cortical subplate
(Englund et al., 2005). Our data also indicate a lack of TBR2+ IPs
in these organoids that might be caused by the increased levels of
TBR1. In fact, TBR2 downregulation occurs upon upregulation
of TBR1, and upon formation of early born neurons that
migrate through the inner zone into the cortical plate (Englund
et al., 2005). Importantly, mouse models showing TBR2
downregulation have been associated to microcephaly (Arnold
et al., 2008), with the decreased brain volume accompanied
by increased neuronal density, a feature also reported in RTT
patients (Schanen et al., 2004) and RTT mouse models (Chen
et al., 2001). Consistently, our results show a clear correlation
between the formation of the early post-mitotic cortical deeper
layers and an increase in neuronal layer thickness, and a decrease
of KI67+ proliferative cells. Additionally, a decreased expression
of PAX6 mRNA and a lower number of HOPX+ oRG cells
observed could be a possible evidence of the imbalance between
neuronal differentiation and maintenance of the progenitor pool.
Our RTT male dorsal organoids did not reveal the same
initial phenotypic alterations observed in the female ones,
further demonstrating the potential capacity of our models to
highlight mutation-dependent alterations in the differentiation/
proliferation equilibrium.
In line with our findings, Li et al. (2014) found that
mutant-MeCP2 serine 421 phosphorylation in progenitor cells,
isolated from adult mouse hippocampus, displayed an imbalance
between proliferation and neuronal differentiation, and that this
imbalance was mediated by alterations of the Notch signaling
pathway (Li et al., 2014). Moreover, Edri et al. verified that
neurons populating the cortical deep layers are generated from
RG progenitors in a Notch-dependent manner. It was also
shown that early progenitor stages require Notch activation to
generate early appearing neurons (Edri et al., 2015). Our data
shows that the premature appearance of deep cortical neurons
observed in MeCP2:R255X dorsal organoids is associated to
HES5 overexpression, which points to the hypothesis that the
observed premature differentiation may be a consequence of
alterations of the Notch regulatory mechanism. In fact, Notch
ligands, effectors and pro-neuronal genes are expressed in an
oscillatory, dynamic and site-specific manner in the developing
mammalian nervous system (Kobayashi and Kageyama, 2010;
Kageyama, 2011). In line with our observations, Bansod et al.
(2017) demonstrated that Hes5-overexpression in mice induced
the early shift from deep to superficial layer neurogenesis
and regulated the timing of neurogenesis. As an alternative
hypothesis, a regulatory mechanism known as lateral inhibition,
which is responsible for the proper maintenance of the pool of
neural progenitors during neurogenesis, may be altered. Under
normal circumstances, the newborn neurons express the Notch
ligand DLL1, activating the Notch signaling in the neighboring
cells, thus inhibiting their neuronal differentiation (Kageyama
et al., 2008). However, when this pathway is deregulated,
neural progenitors prematurely differentiate into early born
Frontiers in Cell and Developmental Biology | www.frontiersin.org 13 December 2020 | Volume 8 | Article 610427
fcell-08-610427 December 5, 2020 Time: 21:24 # 14
Gomes et al. hiPSCs Rett Syndrome Organoids Modeling
neurons. As the mRNA levels of the Notch ligand DLL1 were
decreased in our RTT female organoids, the premature formation
of post-mitotic neurons in these organoids could indicate a
deregulation of Notch signaling pathway, more precisely the
mechanistic process of lateral inhibition. In fact, the previously
mentioned report from Li et al. (2014) also demonstrated
that phosphor-mutant MeCP2 protein has altered promoter
occupancy at the promoters of DLL1, decreasing the levels of
transcription of this Notch ligand (Li et al., 2014). Future studies
should be performed to confirm our hypothesis of alterations
of the Notch signaling lateral inhibition pathway driven by the
MeCP2:R255X mutation.
We also studied the impact of mutated MeCP2 in regulating
neural function and activity in dorsal forebrain organoids
namely by performing SSCI and patch-clamp analysis. Organoid
slices have been commonly used by others (Xiang et al., 2017)
for this type of studies namely because this method allows
the preservation of the original cell to cell interactions and
the maintenance of the 3D organization in the selected part
of the slice. However, in the case of our approach, the 3D
organoids were dissociated and replated 4–5 days before the
analysis because we believe that analyzing networks without
dense cell overlaps is a more accurate way to perform the
recording and the analysis of both calcium imaging and
patch-clamp experiments. Since the organoid forming cells
were capable of re-establishing the self-organized neuronal
networks upon replating, we believe that this approach
allows this functional analysis to capture the interactions
between the cells that were previously composing the
entire 3D organoid, both neurons and progenitor cells. In
addition to SSCI and patch-clamp analysis, also immune
quantifications of pre- and pos-synaptic markers, as well as
dendritic spines characterization, were performed by replating
of the 3D organoids, thus keeping all the manipulation
procedures for functional-related analysis and the respective
results consistent.
Single cell calcium imaging performed at days 44–47 of
differentiation of RTT female dorsal organoids corroborate
the previously raised hypothesis of premature development
of newborn neurons. Later in differentiation, SCCI analysis
showed an increased percentage of cells that do not respond
to KCl or histamine stimulation, suggesting a decrease in
the percentage of cells presenting a neuronal-like profile
along the maturation process. This is consistent with previous
studies showing MeCP2-mutant neurons with altered calcium
signaling (Chen et al., 2003; Marchetto et al., 2010), associated
to an impairment in the expression/sensitivity of VSCC
and consequently to a defective neuronal responsiveness to
depolarization (Gandaglia et al., 2019).
The capacity of human cortical neurons to generate repetitive
AP upon a current depolarization was not detected before 20
gestational weeks (GW), whereas single AP firing was present
as early as 16 GW (Moore et al., 2009). We observed that
neurons in our control dorsal organoids presented features of
maturation, exhibiting electrophysiological activity. Conversely,
the prematurely formed neurons in MeCP2:R255X dorsal
organoids, at day 47, exhibit slow activity, with decreased
firing properties. This was demonstrated by the appearance of
one single AP firing in almost all of the analyzed cells, by
the broad AP half width of the first AP, by the decreased
AP amplitude and by the reduced AP velocity (dV/dt) in
a train of AP firing near threshold. APs are generated by
special types of voltage-gated ion channels embedded in the
plasma membrane, such as voltage-gated potassium and sodium
channels (Johnson et al., 2007; Weick, 2016; Silva et al., 2020).
Thus, our results observed in APs generated by MeCP2:R255X
neurons may potentially indicate the presence of fewer release
sites or less release probability. Our results are aligned with
other studies previously published in the literature. In fact,
electrophysiological recordings of RTT hiPSCs-derived neurons
had already exhibited immature spike characteristics (Marchetto
et al., 2010). Moreover, a different study analyzing RTT
neurons showed dysfunction in AP generation and voltage-
gated Na+ currents (Djuric et al., 2016). Nevertheless, for
the exact determination of potential alterations of neuronal
membrane ion channels, in the future both sodium and
potassium current injections measurements must be performed.
As another demonstration of an altered electrophysiological
profile, synaptic transmission, which requires the existence of
functional neurotransmitter receptors, was also affected in our
RTT female organoids, as determined by analysis of spontaneous
synaptic currents, suggesting the existence of impairments in
neuronal maturation and synaptic connection.
Later in maturation, at day 81, no AP was detected in
dorsal MeCP2:R255X neurons. In agreement with this result,
our analyses also demonstrated a decrease in VGLUT1 puncta,
a specific protein of glutamatergic neurons responsible for
loading glutamate into synaptic vesicles. In contradiction with
these results, an increase in mRNA levels of VGLUT1 was
detected, which could be potentially related with a homeostatic
compensation for the differential number of pre- and post-
synaptic structures observed. In fact, previous studies using
postmortem samples of RTT female patients demonstrated
differential temporal distributions in glutamate levels in the
forebrain (Lane et al., 1999). In agreement with our VGLUT1
puncta analysis, other studies using MECP2-mutated neurons
derived from hiPSCs (Marchetto et al., 2010) or neurons lacking
MECP2 derived from mice (Chao et al., 2007), also revealed
a decrease in VGLUT1 puncta and consequently a decrease in
functional synaptic densities.
As an additional functional characterization, we analyzed the
dendritic spine morphology, as they are known to present a
reduced density in RTT patients (Armstrong, 1995; Zhou et al.,
2006). Accordingly, we observed a reduction of the number
of mushroom and stubby-shaped spines in our RTT neurons,
already reported for other RTT models (Chapleau et al., 2009).
Overall, our RTT female organoids revealed functional
immaturity/impairments, excitatory imbalance and regression
in spine morphology. This can be potentially explained by
the premature formation of early post-mitotic neurons that
possibly lack the spatial-temporal cues needed for a proper
maturation. Moreover, together with other studies reported
in the literature (Blue et al., 1999; Marchetto et al., 2010),
our results suggest an apparent role of MeCP2 in regulating
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glutamatergic synapse formation, synaptic function and neuronal
maturation features.
Upon ventral patterning of RTT hiPSCs, we observed a
significant decrease in the expression of the MGE domain
characteristic marker, NKX2.1, in RTT female ventral
organoids. MGE domain is composed of progenitor cells
that originate GABAergic interneuron subtypes. Thus, this result
is consistent with previous studies using MeCP2-mutant mice
in which GABA-releasing neurons showed reduced inhibitory
neurotransmitter capacity, being responsible for RTT symptoms
such as repetitive behaviors and impaired motor coordination
(Chao et al., 2010). During neurodevelopment, interneurons
formed in MGE begin a migratory process to populate the
dorsal pallium, by performing a tangential migration followed by
integration into neural circuits, undergoing activity-dependent
maturation (Gelman et al., 2012). A study from Sandberg
et al. (2016) demonstrated that the combinatorial binding of
NKX2.1 and LHX6 promotes the transcriptional activation of
genes expressed in cortical migrating interneurons (Sandberg
et al., 2016), influencing the process of interneuron migration.
Moreover, Nkx2.1 mutant-mice demonstrated deficits in the
MGE migration (Anderson et al., 2001). Consistently, we also
found a decrease of DCX expression for ventral MECP2:R255X
organoids. In fact, previous studies in DCX-KO-mouse models
demonstrated that this microtubule-associated protein is crucial
for radial migration of interneurons (Liu et al., 2007), affecting
their number and distribution (Kappeler et al., 2006). In a more
recent study using 3D organoids and monolayer RTT-derived
MeCP2-knockdown hiPSCs, it was also observed a decrease in
DCX expression, and consequently defects in neurogenesis and
neuronal differentiation (Mellios et al., 2017).
Taking together these alterations of the molecular and
functional profile of interneurons, we decided to develop a
more appropriate model to study their migration process
by assembling ventral and dorsal organoids (Bagley et al.,
2017; Xiang et al., 2017; Sloan et al., 2018). By using this
model we observed that neurons traveled a shorter distance
during their migration process when using female RTT fused
organoids and we also observed a decreased percentage of
GFP+ ventral cells integrating into the dorsal part of the
assembloid at early stages of development. So far, no other
studies were yet performed regarding interneuron migration
in the context of RTT. However, it is known that migratory
interneurons integrate into neural dorsal circuits, contributing
to the E/I balance (Gelman et al., 2012), whose disturbance
has been previously reported for RTT (Chao et al., 2010).
It is known that neuron-specific K+ – Cl− co-transporter 2
(KCC2) is a critical downstream gene target of MeCP2, being
responsible for neuronal network formation, maturation delay
and perturbations of GABAergic neurotransmission (Tang et al.,
2016; Ruffolo et al., 2020). It was also proved that signaling
molecules such as GABA neurotransmitter, influenced neuronal
progenitor proliferation and embryonic neuron migration (Wang
et al., 2003). In the future, our fused organoid model may
be treated with the active peptide fragment of Insulin-like
Growth Factor 1 (IGF-1) (Tropea et al., 2009), in order to
study the possible rescue of neuronal migration and network
integration delays, and consequently the rescue of functional
GABA deficits. Additionally, efforts should be made to further
identify which specific subtypes of interneurons are affected. The
disequilibrium between excitation and inhibition (E/I) in RTT
could be a consequence of both glutamatergic neurotransmission
deregulation and GABAergic neurotransmission defects. Our
fused forebrain organoids, resembling neural organization,
differentiation and network formation of both dorsal and ventral
regions, and containing both GABAergic and glutamatergic
neuronal sub-types, could be intensively used for the study of the
nature and mode of action of the local signals responsible for the
(E/I) disequilibrium of different RTT patients.
CONCLUSION
Our model highlights the impact of MeCP2 mutations in different
stages and brain regions during forebrain development. We have
observed previously described aspects of the disease, particularly
for later stages, which have been reported for both hiPSC-
derived cells and animal models, suggesting the relevance of
our platform for this type of studies. However, the model
also demonstrates that different mutations are associated to
distinct phenotype characteristics, as revealed by the results
obtained with two different RTT cell lines. Importantly, our
model revealed early developmental alterations in one female
RTT-derived cell line, which have not been revealed before
using other models, probably because our platform provides
an improved recapitulation of the initial stages of cortical
layer formation. Overall, we were able to show that our RTT
forebrain organoid models can greatly help toward a better
understanding of the pathophysiology of RTT in a patient-
specific context, and for further testing of potential candidate
drugs or other therapeutic strategies in RTT patient-specific
organoids. An added value of our investigation relies on the
fact that all the significant differences observed are based on
comparisons performed between two hiPSC lines with the same
genetic background (isogenic pair). In the future, our conclusions
must be confirmed by extending our work to studies with other
cell lines of the same patient and additional cell lines from
other patients carrying the same mutation. Nevertheless, we truly
believe that our results are reliable and that our work at this stage
is already a valuable and innovative contribution to the field.
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